China Antidiabetic Biguanides Industry 2016 Deep Market Research Report
- QYR405644
- 138 Pages
- February 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Antidiabetic Biguanides market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Antidiabetic Biguanides industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 154 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Antidiabetic Biguanides
1.2 Classification of Antidiabetic Biguanides
1.2.1 Designed for Gas
1.2.2 Designed for Air
1.2.3 Designed for Breathing Air
1.2.4 Designed for Particulate
1.2.5 Not Specified
1.3 Applications of Antidiabetic Biguanides
1.4 Industry Chain Structure of Antidiabetic Biguanides
1.5 Industry Overview of Antidiabetic Biguanides
1.6 Industry Policy Analysis of Antidiabetic Biguanides
1.7 Industry News Analysis of Antidiabetic Biguanides
2 Manufacturing Cost Structure Analysis of Antidiabetic Biguanides
2.1 Bill of Materials (BOM) of Antidiabetic Biguanides
2.2 BOM Price Analysis of Antidiabetic Biguanides
2.3 Labor Cost Analysis of Antidiabetic Biguanides
2.4 Depreciation Cost Analysis of Antidiabetic Biguanides
2.5 Manufacturing Cost Structure Analysis of Antidiabetic Biguanides
2.6 Manufacturing Process Analysis of Antidiabetic Biguanides
2.7 China Price, Cost and Gross of Antidiabetic Biguanides 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of China Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of China Key Antidiabetic Biguanides Manufacturers in 2015
3.3 R&D Status and Technology Source of China Antidiabetic Biguanides Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of China Antidiabetic Biguanides Key Manufacturers in 2015
4 Production Analysis of Antidiabetic Biguanides by Regions, Type, and Applications
4.1 China Production of Antidiabetic Biguanides by Regions 2011-2016
4.2 China Production of Antidiabetic Biguanides by Type 2011-2016
4.3 China Sales of Antidiabetic Biguanides by Applications 2011-2016
4.4 Price Analysis of China Antidiabetic Biguanides Key Manufacturers in 2015
4.5 China Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Antidiabetic Biguanides 2011-2016
5 Consumption Volume and Consumption Value Analysis of Antidiabetic Biguanides by Regions
5.1 China Consumption Volume of Antidiabetic Biguanides by Regions 2011-2016
5.2 China Consumption Value of Antidiabetic Biguanides by Regions 2011-2016
5.3 China Consumption Price Analysis of Antidiabetic Biguanides by Regions 2011-2016
6 Analysis of Antidiabetic Biguanides Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Antidiabetic Biguanides 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Antidiabetic Biguanides 2014-2015
6.3 Sales Overview of Antidiabetic Biguanides 2011-2016
6.4 Supply, Consumption and Gap of Antidiabetic Biguanides 2011-2016
6.5 Import, Export and Consumption of Antidiabetic Biguanides 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Antidiabetic Biguanides 2011-2016
7 Analysis of Antidiabetic Biguanides Industry Key Manufacturers
7.1 Sanofi
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Sanofi SWOT Analysis
7.2 Takeda Pharmaceuticals
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Takeda Pharmaceuticals SWOT Analysis
7.3 Eli Lilly
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Eli Lilly SWOT Analysis
7.4 Merck & Co.
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Merck & Co. SWOT Analysis
7.5 Novo Nordisk
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Novo Nordisk SWOT Analysis
7.6 Bristol-Myers Squibb
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Bristol-Myers Squibb SWOT Analysis
7.7 Pfizer
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Pfizer SWOT Analysis
7.8 AstraZeneca
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 AstraZeneca SWOT Analysis
7.9 GlaxoSmithKline
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 GlaxoSmithKline SWOT Analysis
7.10 Boehringer Ingelheim
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Boehringer Ingelheim SWOT Analysis
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Antidiabetic Biguanides Product Types
8.5 Market Share Analysis of Different Antidiabetic Biguanides Price Levels
8.6 Gross Margin Analysis of Different Antidiabetic Biguanides Applications
9 Marketing Trader or Distributor Analysis of Antidiabetic Biguanides
9.1 Marketing Channels Status of Antidiabetic Biguanides
9.2 Traders or Distributors of Antidiabetic Biguanides with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Antidiabetic Biguanides
9.4 China Import, Export and Trade Analysis of Antidiabetic Biguanides
10 Development Trend of Antidiabetic Biguanides Industry 2016-2021
10.1 Capacity and Production Overview of Antidiabetic Biguanides 2016-2021
10.2 Production Market Share by Product Types of Antidiabetic Biguanides 2016-2021
10.3 Sales and Sales Revenue Overview of Antidiabetic Biguanides 2016-2021
10.4 China Sales of Antidiabetic Biguanides by Applications 2016-2021
10.5 Import, Export and Consumption of Antidiabetic Biguanides 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Antidiabetic Biguanides 2016-2021
11 Industry Chain Suppliers of Antidiabetic Biguanides with Contact Information
11.1 Major Raw Materials Suppliers of Antidiabetic Biguanides with Contact Information
11.2 Manufacturing Equipment Suppliers of Antidiabetic Biguanides with Contact Information
11.3 Major Players of Antidiabetic Biguanides with Contact Information
11.4 Key Consumers of Antidiabetic Biguanides with Contact Information
11.5 Supply Chain Relationship Analysis of Antidiabetic Biguanides
12 New Project Investment Feasibility Analysis of Antidiabetic Biguanides
12.1 New Project SWOT Analysis of Antidiabetic Biguanides
12.2 New Project Investment Feasibility Analysis of Antidiabetic Biguanides
13 Conclusion of the China Antidiabetic Biguanides Industry 2016 Market Research Report
List Of Tables and Figures
Figure Picture of Antidiabetic Biguanides
Table Product Specifications of Antidiabetic Biguanides
Table Classification of Antidiabetic Biguanides
Figure China Sales Market Share of Antidiabetic Biguanides by Product Types in 2015
Table Applications of Antidiabetic Biguanides
Figure China Sales Market Share of Antidiabetic Biguanides by Applications in 2015
Figure Industry Chain Structure of Antidiabetic Biguanides
Table China Industry Overview of Antidiabetic Biguanides
Table Industry Policy of Antidiabetic Biguanides
Table Industry News List of Antidiabetic Biguanides
Table Bill of Materials (BOM) of Antidiabetic Biguanides
Table Bill of Materials (BOM) Price of Antidiabetic Biguanides
Table Labor Cost of Antidiabetic Biguanides
Table Depreciation Cost of Antidiabetic Biguanides
Table Manufacturing Cost Structure Analysis of Antidiabetic Biguanides in 2015
Figure Manufacturing Process Analysis of Antidiabetic Biguanides
Table China Price Analysis of Antidiabetic Biguanides 2011-2016 (USD/Dose)
Table China Cost Analysis of Antidiabetic Biguanides 2011-2016 (USD/Dose)
Table China Gross Analysis of Antidiabetic Biguanides 2011-2016
Table Capacity (Dose) and Commercial Production Date of China Antidiabetic Biguanides Key Manufacturers in 2015
Table Manufacturing Plants Distribution of China Key Antidiabetic Biguanides Manufacturers in 2015
Table R&D Status and Technology Source of China Antidiabetic Biguanides Key Manufacturers in 2015
Table Raw Materials Sources Analysis of China and China Antidiabetic Biguanides Key Manufacturers in 2015
Table China Production of Antidiabetic Biguanides by Regions 2011-2016 (Dose)
Table China Production Market Share of Antidiabetic Biguanides by Regions 2011-2016
Figure China Production Market Share of Antidiabetic Biguanides by Regions in 2014
Figure China Production Market Share of Antidiabetic Biguanides by Regions in 2015
Table China Production of Antidiabetic Biguanides by Types in 2011-2016 (Dose)
Table China Production Market Share of Antidiabetic Biguanides by Type in 2011-2016
Figure China Production Market Share of Antidiabetic Biguanides by Type in 2014
Figure China Production Market Share of Antidiabetic Biguanides by Type in 2015
Table China Sales of Antidiabetic Biguanides by Applications 2011-2016 (Dose)
Table China Production Market Share of Antidiabetic Biguanides by Applications 2011-2016
Figure China Production Market Share of Antidiabetic Biguanides by Applications in 2014
Figure China Production Market Share of Antidiabetic Biguanides by Applications in 2015
Table Price Comparison of China Antidiabetic Biguanides Key Manufacturers in 2015 (USD/Dose)
Table China Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Antidiabetic Biguanides 2011-2016
Table China Consumption Volume of Antidiabetic Biguanides by Regions 2011-2016 (Dose)
Table China Consumption Volume Market Share of Antidiabetic Biguanides by Regions 2011-2016
Figure China Consumption Volume Market Share of Antidiabetic Biguanides by Regions in 2014
Figure China Consumption Volume Market Share of Antidiabetic Biguanides by Regions in 2015
Table China Consumption Value of Antidiabetic Biguanides by Regions 2011-2016 (M USD)
Table China Consumption Value Market Share of Antidiabetic Biguanides by Regions 2011-2016
Figure China Consumption Value Market Share of Antidiabetic Biguanides by Regions in 2014
Figure China Consumption Value Market Share of Antidiabetic Biguanides by Regions in 2015
Table Consumption Price of Antidiabetic Biguanides by Regions 2011-2016 (USD/Dose)
Table China and Major Manufacturers Capacity of Antidiabetic Biguanides 2011-2016 (Dose)
Table China Capacity Market Share of Major Antidiabetic Biguanides Manufacturers 2011-2016
Table China and Major Manufacturers Production of Antidiabetic Biguanides 2011-2016 (Dose)
Table China Production Market Share of Major Antidiabetic Biguanides Manufacturers 2011-2016
Table China and Major Manufacturers Sales of Antidiabetic Biguanides 2011-2016 (Dose)
Table China Sales Market Share of Major Antidiabetic Biguanides Manufacturers 2011-2016
Table China and Major Manufacturers Sales Revenue of Antidiabetic Biguanides 2011-2016 (M USD)
Table China Sales Revenue Market Share of Major Antidiabetic Biguanides Manufacturers 2011-2016
Figure China Capacity (Dose), Production (Dose) and Growth Rate of Antidiabetic Biguanides 2011-2016
Figure China Capacity Utilization Rate of Antidiabetic Biguanides 2011-2016
Figure China Sales Revenue (M USD) and Growth Rate of Antidiabetic Biguanides 2011-2016
Figure China Production Market Share of Major Antidiabetic Biguanides Manufacturers in 2014
Figure China Production Market Share of Major Antidiabetic Biguanides Manufacturers in 2015
Figure China Sales Market Share of Major Antidiabetic Biguanides Manufacturers in 2014
Figure China Sales Market Share of Major Antidiabetic Biguanides Manufacturers in 2015
Figure China Sales (Dose) and Growth Rate of Antidiabetic Biguanides 2011-2016
Table China Supply, Consumption and Gap of Antidiabetic Biguanides 2011-2016 (Dose)
Table China Import, Export and Consumption of Antidiabetic Biguanides 2011-2016 (Dose)
Table Price of China Antidiabetic Biguanides Major Manufacturers 2011-2016 (USD/Dose)
Table Gross Margin of China Antidiabetic Biguanides Major Manufacturers 2011-2016
Table China and Major Manufacturers Revenue of Antidiabetic Biguanides 2011-2016 (M USD)
Table China Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antidiabetic Biguanides 2011-2016
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of Sanofi
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sanofi 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Sanofi 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Sanofi 2011-2016
Table Sanofi Antidiabetic Biguanides SWOT Analysis
Table Takeda Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of Takeda Pharmaceuticals
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Takeda Pharmaceuticals 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Takeda Pharmaceuticals 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Takeda Pharmaceuticals 2011-2016
Table Takeda Pharmaceuticals Antidiabetic Biguanides SWOT Analysis
Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of Eli Lilly
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Eli Lilly 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Eli Lilly 2011-2016
Table Eli Lilly Antidiabetic Biguanides SWOT Analysis
Table Merck & Co. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of Merck & Co.
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck & Co. 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Merck & Co. 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Merck & Co. 2011-2016
Table Merck & Co. Antidiabetic Biguanides SWOT Analysis
Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of Novo Nordisk
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Novo Nordisk 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Novo Nordisk 2011-2016
Table Novo Nordisk Antidiabetic Biguanides SWOT Analysis
Table Bristol-Myers Squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of Bristol-Myers Squibb
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Bristol-Myers Squibb 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Bristol-Myers Squibb 2011-2016
Table Bristol-Myers Squibb Antidiabetic Biguanides SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of Pfizer
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Pfizer 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Pfizer 2011-2016
Table Pfizer Antidiabetic Biguanides SWOT Analysis
Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of AstraZeneca
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of AstraZeneca 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of AstraZeneca 2011-2016
Table AstraZeneca Antidiabetic Biguanides SWOT Analysis
Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of GlaxoSmithKline
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of GlaxoSmithKline 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of GlaxoSmithKline 2011-2016
Table GlaxoSmithKline Antidiabetic Biguanides SWOT Analysis
Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Antidiabetic Biguanides Picture and Specifications of Boehringer Ingelheim
Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016
Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Boehringer Ingelheim 2011-2016
Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Boehringer Ingelheim 2011-2016
Table Boehringer Ingelheim Antidiabetic Biguanides SWOT Analysis
Table Antidiabetic Biguanides Price by Regions 2011-2016
Table Antidiabetic Biguanides Price by Product Types 2011-2016
Table Antidiabetic Biguanides Price by Companies 2011-2016
Table Antidiabetic Biguanides Gross Margin by Companies 2011-2016
Table Price Comparison of Antidiabetic Biguanides by Regions 2011-2016 (USD/Dose)
Table Price of Different Antidiabetic Biguanides Product Types (USD/Dose)
Table Market Share of Different Antidiabetic Biguanides Price Level
Table Gross Margin of Different Antidiabetic Biguanides Applications
Table Marketing Channels Status of Antidiabetic Biguanides
Table Traders or Distributors of Antidiabetic Biguanides with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Antidiabetic Biguanides (USD/Dose) in 2015
Table China Import, Export, and Trade of Antidiabetic Biguanides (Dose)
Figure China Capacity (Dose), Production (Dose) and Growth Rate of Antidiabetic Biguanides 2016-2021
Figure China Capacity Utilization Rate of Antidiabetic Biguanides 2016-2021
Table China Antidiabetic Biguanides Production by Type 2016-2021 (Dose)
Table China Antidiabetic Biguanides Production Market Share by Type 2016-2021
Figure China Production Market Share of Antidiabetic Biguanides by Type in 2021
Figure China Sales (Dose) and Growth Rate of Antidiabetic Biguanides 2016-2021
Figure China Sales Revenue (Million USD) and Growth Rate of Antidiabetic Biguanides 2016-2021
Figure China Sales of Antidiabetic Biguanides by Applications 2016-2021 (Dose)
Table China Production Market Share of Antidiabetic Biguanides by Applications 2016-2021
Figure China Production Market Share of Antidiabetic Biguanides by Applications in 2021
Table China Production, Import, Export and Consumption of Antidiabetic Biguanides 2016-2021 (Dose)
Table China Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antidiabetic Biguanides 2016-2021
Table Major Raw Materials Suppliers of Antidiabetic Biguanides with Contact Information
Table Manufacturing Equipment Suppliers of Antidiabetic Biguanides with Contact Information
Table Major Players of Antidiabetic Biguanides with Contact Information
Table Key Consumers of Antidiabetic Biguanides with Contact Information
Table Supply Chain Relationship Analysis of Antidiabetic Biguanides
Table New Project SWOT Analysis of Antidiabetic Biguanides
Table New Project Investment Feasibility Analysis of Antidiabetic Biguanides
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
